e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
Thomas Marichal (Liège, Belgium)
Source:
ERS Lung Science Conference 2019
Number:
5
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Thomas Marichal (Liège, Belgium). Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. ERS Lung Science Conference 2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Autoimmunity in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017
Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model
Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017
Year: 2017
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006
LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production
in vitro
and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma
in vivo
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013
Levofloxacin prevents eosinophil activation and asthma exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 207s
Year: 2006
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
Cytokine regulation of the chronicle inflammation of bronchial asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 590s
Year: 2005
IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Role of neutrophils in maintenance of severity of non-allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 585s
Year: 2007
Extracellular nucleotides contribute to the pathogenesis of viral-induced exacerbations in COPD via P2X4/P2X7-receptor activation
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
The abnormalities in spontaneous and Fas-induced apoptosis in atopic bronchial asthma (ABA): the key to chronic lung inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept